MERCK KGAA NAM.SP.ADR Net Assets

Latest as of December 2025: €28.66 Billion EUR ≈ $33.51 Billion USD

MERCK KGAA NAM.SP.ADR net assets. Based on the latest financial reports, MERCK KGAA NAM.SP.ADR (MRKC) has net assets worth €28.66 Billion EUR (≈ $33.51 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€51.53 Billion ≈ $60.24 Billion USD) and total liabilities (€22.87 Billion ≈ $26.73 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore MRKC net asset momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets €28.66 Billion
% of Total Assets 55.62%
Annual Growth Rate 10.99%
5-Year Change 33.83%
10-Year Change N/A
Growth Volatility 11.25

Net Assets of MERCK KGAA NAM.SP.ADR (2020–2025)

Net assets of MERCK KGAA NAM.SP.ADR from 2020 to 2025. This chart illustrates how MERCK KGAA NAM.SP.ADR's net assets have evolved over time, based on quarterly financial data. See net asset quality index of MERCK KGAA NAM.SP.ADR to measure how much of total assets are equity-financed.

Annual Net Assets for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual net assets of MERCK KGAA NAM.SP.ADR from 2020 to 2025. For live market cap and overall valuation, see MRKC stock market capitalisation.

Year Net Assets Change
2025-12-31 €28.66 Billion
≈ $33.51 Billion
-4.43%
2024-12-31 €29.99 Billion
≈ $35.06 Billion
+12.08%
2023-12-31 €26.75 Billion
≈ $31.28 Billion
+2.88%
2022-12-31 €26.00 Billion
≈ $30.40 Billion
+21.43%
2021-12-31 €21.42 Billion
≈ $25.04 Billion
+25.85%
2020-12-31 €17.02 Billion
≈ $19.89 Billion
--

Equity Component Analysis

This analysis shows how different components contribute to MERCK KGAA NAM.SP.ADR's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 94.2% over the analyzed period, indicating profitable operations and earnings retention.

MERCK KGAA NAM.SP.ADR Net Assets Breakdown (December 2025)

MERCK KGAA NAM.SP.ADR net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings €24.04 Billion 84.08%
Other Components €4.55 Billion 15.92%
Total Equity €28.59 Billion 100.00%

MERCK KGAA NAM.SP.ADR Competitors by Market Cap

The table below lists competitors of MERCK KGAA NAM.SP.ADR ranked by their market capitalization.

Company Market Cap
Brookfield Infrastructure Partners LP
NYSE:BIP
$17.08 Billion
Geberit AG
SW:GEBN
$17.10 Billion
Amer Sports, Inc.
NYSE:AS
$17.12 Billion
Powszechny Zaklad Ubezpieczen SA
WAR:PZU
$17.14 Billion
RENAU.UNSP.ARD 1/5 EO-20
F:56S0
$17.02 Billion
China Shipbuilding Industry Co Ltd
SHG:601989
$17.02 Billion
ASICS CORP.(UNSP.ADR)/1
F:ASI
$17.00 Billion
Essex Property Trust Inc
NYSE:ESS
$16.98 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MERCK KGAA NAM.SP.ADR's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 29,912,000,000 to 28,592,000,000, a change of -1,320,000,000 (-4.4%).
  • Net income of 2,608,000,000 contributed positively to equity growth.
  • Dividend payments of 284,000,000 reduced retained earnings.
  • Other factors decreased equity by 3,644,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €2.61 Billion +9.12%
Dividends Paid €284.00 Million -0.99%
Other Changes €-3.64 Billion -12.74%
Total Change €- -4.41%

Book Value vs Market Value Analysis

This analysis compares MERCK KGAA NAM.SP.ADR's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.34x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 0.58x to 0.34x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 €38.98 €22.60 x
2021-12-31 €49.08 €22.60 x
2022-12-31 €59.63 €22.60 x
2023-12-31 €61.36 €22.60 x
2024-12-31 €68.80 €22.60 x
2025-12-31 €65.76 €22.60 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MERCK KGAA NAM.SP.ADR utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.12%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 12.36%
  • • Asset Turnover: 0.41x
  • • Equity Multiplier: 1.80x
  • Recent ROE (9.12%) is below the historical average (11.31%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 11.73% 11.33% 0.42x 2.47x €292.40 Million
2021 14.32% 15.52% 0.43x 2.13x €921.20 Million
2022 12.83% 14.96% 0.46x 1.87x €733.30 Million
2023 10.58% 13.45% 0.43x 1.82x €156.00 Million
2024 9.28% 13.13% 0.41x 1.72x €-214.20 Million
2025 9.12% 12.36% 0.41x 1.80x €-251.20 Million

Industry Comparison

This section compares MERCK KGAA NAM.SP.ADR's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $9,729,794,157
  • Average return on equity (ROE) among peers: -99.76%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MERCK KGAA NAM.SP.ADR (MRKC) €28.66 Billion 11.73% 0.80x $17.07 Billion
SHANG.FOS.PHARM.GR.H YC 1 (08HH) $56.62 Billion 4.21% 1.00x $1.20 Billion
PEPTONIC MEDICAL (28L) $47.09 Million -78.27% 0.82x $5.52 Million
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) $5.05 Billion 11.11% 0.41x $692.11 Million
WEST ISLAND BRANDS INC. (39N0) $3.27 Million -157.21% 0.88x $1.34 Million
HANSOH PHARMAC. HD-00001 (3KY) $35.36 Billion 15.71% 0.13x $22.06 Billion
AYURCANN HOLDINGS CORP. (3ZQ0) $534.88K -741.80% 26.77x $97.35K
CERENO SCIENTIFIC AB B (4A1) $201.51 Million -13.72% 0.07x $60.94 Million
MAPLE LEAF GREEN WORLD (4HV0) $-8.83 Million 0.00% 0.00x $504.30K
LORDS CO. WORLDW. HOLD. (4XM) $-1.01 Million 0.00% 0.00x $134.78K
RED LIGHT HOLLAND CORP. (4YX) $20.26 Million -37.64% 0.19x $6.62 Million

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1431 Global
#323 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more